21st Austria weekly - Agrana (15/04/2026)

Agrana: Fruit, starch an sugar company AGRANA generated operating profit before exceptional items and results of equity-accounted joint ventures in its 2025|26 financial year (1 March 2025 to 28 February 2026) in an amount of € 81.2 million (prior year: € 76.5 million). Exceptional items amounted to € -74.1 million (prior year: € -36.4 million) and include non-cash impairments of assets in the ACS – Sugar segment with a volume of € 46.0 million. EBIT amounted to € 3.2 million (prior year: € 40.5 million). Consolidated revenue amounted to € 3,237.3 million (prior year: € 3,514.0 million). For the 2026|27 financial year (1 March 2026 to 28 February 2027), AGRANA forecasts EBIT which is expected to be very significantly (more than 50%) higher than in the prior year and within a range of € 70 to 90 million. A slight increase (1% to 5%) in consolidated revenue is forecast.
Agrana: weekly performance: -0.42%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (15/04/2026)

Christian Drastil: Wiener Börse Plausch

Börsepeople im Podcast S25/08: Franz Schellhorn

Bildnachweis

1. Agrana Geschäftsbericht 2021 - https://boerse-social.com/companyreports/2022/214717/agrana_geschaftsbericht_2021   >> Öffnen auf photaq.com

Aktien auf dem Radar:Mayr-Melnhof, Bajaj Mobility AG, Semperit, Amag, Austriacard Holdings AG, Agrana, Flughafen Wien, OMV, Uniqa, UBM, Rosgix, Rosenbauer, Addiko Bank, Athos Immobilien, AT&S, FACC, Heid AG, Reploid Group AG, Marinomed Biotech, Wolford, Warimpex, Zumtobel, EuroTeleSites AG, Polytec Group, BKS Bank Stamm, CPI Europe AG, Österreichische Post, Telekom Austria, Infineon, Caterpillar, Fresenius Medical Care.

Random Partner

---

Marinomed
Marinomed hat die Vision, das Leben von Patienten, die an Krankheiten mit unzureichenden Behandlungsmöglichkeiten leiden, in zwei wichtigen therapeutischen Bereichen nachhaltig zu verbessern: Virologie und Immunologie.

>> Besuchen Sie 55 weitere Partner auf boerse-social.com/partner